Collegium Pharmaceutical, Inc. (COLL) vs Tilray Brands, Inc. (TLRY)
Collegium Pharmaceutical, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $737.1M against $603.0M — 1.2× the size. Tilray Brands, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 14.7×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 14.3% against 11.5%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −13.3%) and the higher return on invested capital (7.85% vs −2.27%). Across the 20 metrics below, Collegium Pharmaceutical, Inc. leads on 14 and Tilray Brands, Inc. on 6.
Valuation
Profitability
| Metric | COLL | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.02% | 28.45% | 53.94% |
| Operating margin | 19.48% | (6.88%) | 0.00% |
| Net margin | 5.93% | (13.26%) | 0.00% |
| Free cash flow margin | 40.62% | (10.77%) | 0.00% |
| Return on equity | 17.61% | (7.87%) | (0.40%) |
| Return on assets | 2.57% | (5.52%) | (3.32%) |
| Return on invested capital | 7.85% | (2.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack